4,729 Shares in Sanofi (NASDAQ:SNY) Acquired by Certior Financial Group LLC

Certior Financial Group LLC acquired a new position in shares of Sanofi (NASDAQ:SNY) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 4,729 shares of the company’s stock, valued at approximately $228,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Charles Schwab Investment Management Inc. raised its position in shares of Sanofi by 31.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 139,505 shares of the company’s stock worth $8,040,000 after acquiring an additional 33,105 shares in the last quarter. HighTower Advisors LLC lifted its position in Sanofi by 1.0% during the third quarter. HighTower Advisors LLC now owns 88,100 shares of the company’s stock valued at $5,081,000 after purchasing an additional 848 shares during the period. IHT Wealth Management LLC purchased a new stake in Sanofi during the third quarter valued at $227,000. Stifel Financial Corp boosted its holdings in shares of Sanofi by 2.0% in the third quarter. Stifel Financial Corp now owns 562,547 shares of the company’s stock worth $32,420,000 after buying an additional 10,892 shares during the last quarter. Finally, State Street Corp boosted its stake in shares of Sanofi by 0.5% during the 3rd quarter. State Street Corp now owns 56,734 shares of the company’s stock worth $3,270,000 after acquiring an additional 264 shares during the last quarter. 14.04% of the stock is currently owned by hedge funds and other institutional investors.

Sanofi Price Performance

SNY opened at $51.98 on Monday. The stock’s 50-day moving average price is $55.37 and its 200 day moving average price is $52.65. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. Sanofi has a 12-month low of $45.22 and a 12-month high of $60.12. The firm has a market cap of $131.92 billion, a price-to-earnings ratio of 20.88, a PEG ratio of 1.01 and a beta of 0.57.

Sanofi (NASDAQ:SNY) last released its quarterly earnings data on Thursday, January 30th. The company reported $0.70 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. As a group, sell-side analysts expect that Sanofi will post 4.36 earnings per share for the current year.

Analyst Upgrades and Downgrades

SNY has been the topic of several research analyst reports. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. The Goldman Sachs Group started coverage on Sanofi in a research note on Friday, March 21st. They issued a “neutral” rating and a $65.00 price objective for the company. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a report on Thursday, January 30th. Finally, Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Three equities research analysts have rated the stock with a hold rating, one has given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $62.50.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.